1. Home
  2. RSI vs MESO Comparison

RSI vs MESO Comparison

Compare RSI & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RSI
  • MESO
  • Stock Information
  • Founded
  • RSI 2012
  • MESO 2004
  • Country
  • RSI United States
  • MESO Australia
  • Employees
  • RSI N/A
  • MESO N/A
  • Industry
  • RSI Services-Misc. Amusement & Recreation
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RSI Consumer Discretionary
  • MESO Health Care
  • Exchange
  • RSI Nasdaq
  • MESO Nasdaq
  • Market Cap
  • RSI 1.3B
  • MESO 1.3B
  • IPO Year
  • RSI N/A
  • MESO N/A
  • Fundamental
  • Price
  • RSI $14.84
  • MESO $11.06
  • Analyst Decision
  • RSI Strong Buy
  • MESO Buy
  • Analyst Count
  • RSI 9
  • MESO 4
  • Target Price
  • RSI $16.00
  • MESO $18.00
  • AVG Volume (30 Days)
  • RSI 1.4M
  • MESO 213.0K
  • Earning Date
  • RSI 07-30-2025
  • MESO 08-28-2025
  • Dividend Yield
  • RSI N/A
  • MESO N/A
  • EPS Growth
  • RSI N/A
  • MESO N/A
  • EPS
  • RSI 0.10
  • MESO N/A
  • Revenue
  • RSI $969,062,000.00
  • MESO $5,670,000.00
  • Revenue This Year
  • RSI $15.68
  • MESO $178.09
  • Revenue Next Year
  • RSI $14.13
  • MESO $305.06
  • P/E Ratio
  • RSI $152.15
  • MESO N/A
  • Revenue Growth
  • RSI 29.86
  • MESO N/A
  • 52 Week Low
  • RSI $8.52
  • MESO $5.78
  • 52 Week High
  • RSI $16.78
  • MESO $22.00
  • Technical
  • Relative Strength Index (RSI)
  • RSI 60.00
  • MESO 50.02
  • Support Level
  • RSI $14.91
  • MESO $10.32
  • Resistance Level
  • RSI $15.75
  • MESO $10.86
  • Average True Range (ATR)
  • RSI 0.42
  • MESO 0.35
  • MACD
  • RSI -0.02
  • MESO 0.00
  • Stochastic Oscillator
  • RSI 60.76
  • MESO 45.04

About RSI Rush Street Interactive Inc.

Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

Share on Social Networks: